Gibson Christopher

Insider CIK 1856369 · PACB Director · RXRX Chief Executive Officer, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-06-05	2026-06-05	40,000	—	$0	4,263,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-06-05	2026-06-05	40,000	—	$0	923,735	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-06-05	2026-06-05	40,000	$3.62	$144.8K	883,735	SEC↗
PACB PACIFIC BIOSCIENCES OF CAL	A Award deriv	2026-06-03	2026-06-04	74,497	—	$0	74,497	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-05-22	2026-05-27	40,000	—	$0	4,303,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-05-22	2026-05-27	40,000	$3.08	$123.2K	883,735	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-05-22	2026-05-27	40,000	—	$0	923,735	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2026-05-15	2026-05-19	22,821	$3.04	$69.4K	883,735	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-05-07	2026-05-08	60,000	—	$0	4,343,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-05-07	2026-05-08	40,000	$3.37	$134.8K	926,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-05-07	2026-05-08	60,000	—	$0	966,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2026-05-07	2026-05-08	20,000	—	$0	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-04-22	2026-04-24	40,000	—	$0	4,403,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-04-22	2026-04-24	40,000	$3.61	$144.4K	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-04-22	2026-04-24	40,000	—	$0	946,556	SEC↗
PACB PACIFIC BIOSCIENCES OF CAL	A Award deriv	2026-04-08	2026-04-10	77,842	—	$0	77,842	SEC↗
PACB PACIFIC BIOSCIENCES OF CAL	A Award	2026-04-08	2026-04-10	57,473	—	$0	111,386	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-04-07	2026-04-08	40,000	—	$0	4,443,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-04-07	2026-04-08	40,000	$3.10	$124.0K	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-04-07	2026-04-08	40,000	—	$0	946,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-03-23	2026-03-25	40,000	—	$0	4,483,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-03-23	2026-03-25	40,000	—	$0	946,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-03-23	2026-03-25	40,000	$3.25	$130.0K	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-03-09	2026-03-11	20,000	—	$0	4,523,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2026-03-09	2026-03-11	20,000	—	$0	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-03-09	2026-03-11	20,000	—	$0	926,556	SEC↗
PACB PACIFIC BIOSCIENCES OF CAL	A Award deriv	2026-03-03	2026-03-05	73,087	—	$0	73,087	SEC↗
PACB PACIFIC BIOSCIENCES OF CAL	A Award	2026-03-03	2026-03-05	53,913	—	$0	53,913	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-02-19	2026-02-19	40,000	—	$0	4,543,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-02-19	2026-02-19	40,000	—	$0	946,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-02-19	2026-02-19	40,000	$3.46	$138.4K	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2026-02-17	2026-02-19	27,265	$3.49	$95.2K	906,556	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2026-02-06	2026-02-06	10,364	$3.56	$36.9K	933,821	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award	2026-02-06	2026-02-06	30,346	—	$0	944,185	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-02-04	2026-02-06	40,000	—	$0	4,583,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-02-04	2026-02-06	40,000	—	$0	953,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-02-04	2026-02-06	40,000	$4.12	$164.8K	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-01-20	2026-01-22	40,000	—	$0	4,623,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-01-20	2026-01-22	40,000	$4.47	$178.8K	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-01-20	2026-01-22	40,000	—	$0	953,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2026-01-05	2026-01-07	60,000	—	$0	4,663,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2026-01-05	2026-01-07	20,000	—	$0	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2026-01-05	2026-01-07	60,000	—	$0	973,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2026-01-05	2026-01-07	40,000	$4.25	$170.0K	933,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-12-19	2025-12-19	40,000	—	$0	4,723,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-12-19	2025-12-19	40,000	—	$0	953,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-12-19	2025-12-19	40,000	$4.50	$180.0K	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-12-04	2025-12-05	60,000	—	$0	4,763,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-12-04	2025-12-05	40,000	$4.63	$185.2K	933,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2025-12-04	2025-12-05	20,000	—	$0	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-12-04	2025-12-05	60,000	—	$0	973,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-11-19	2025-11-19	40,000	—	$0	4,823,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-11-19	2025-11-19	40,000	—	$0	953,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-11-19	2025-11-19	40,000	$4.16	$166.4K	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2025-11-17	2025-11-19	40,390	$4.14	$167.2K	913,839	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-11-04	2025-11-06	60,000	—	$0	4,863,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2025-11-04	2025-11-06	20,000	—	$0	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-11-04	2025-11-06	60,000	—	$0	1,014,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-11-04	2025-11-06	40,000	$5.21	$208.4K	974,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-10-23	2025-10-24	100,000	—	$0	4,923,334	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-10-23	2025-10-24	100,000	$5.70	$570.0K	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-10-23	2025-10-24	100,000	—	$0	1,054,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-10-10	2025-10-10	120,000	—	$0	5,133,034	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-10-10	2025-10-10	100,000	$6.04	$604.0K	974,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-10-10	2025-10-10	120,000	—	$0	1,074,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2025-10-10	2025-10-10	20,000	—	$0	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-09-25	2025-09-26	0	—	$0	5,253,034	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-09-25	2025-09-26	100,000	$4.76	$476.0K	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-09-25	2025-09-26	100,000	—	$0	1,054,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-09-10	2025-09-12	120,000	—	$0	5,253,034	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-09-10	2025-09-12	100,000	$4.71	$471.0K	974,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2025-09-10	2025-09-12	20,000	—	$0	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-09-10	2025-09-12	120,000	—	$0	1,074,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-08-26	2025-08-28	100,000	—	$0	5,373,034	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-08-26	2025-08-28	100,000	—	$0	1,054,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-08-26	2025-08-28	100,000	$4.84	$484.0K	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2025-08-15	2025-08-19	40,390	$5.64	$227.8K	954,229	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-08-11	2025-08-13	423,666	—	$0	5,473,034	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-08-11	2025-08-13	100,000	—	$0	386,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-08-11	2025-08-13	17,875	—	$0	50,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-08-11	2025-08-13	17,875	—	$0	17,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-08-11	2025-08-13	100,000	$5.28	$528.0K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-08-11	2025-08-13	100,000	—	$0	100,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-08-11	2025-08-13	17,875	$5.28	$94.4K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2025-08-11	2025-08-13	10,000	—	$0	994,619	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-08-11	2025-08-13	500,300	$5.28	$2.64M	1,004,619	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-08-11	2025-08-13	423,666	—	$0	1,504,919	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2025-05-15	2025-05-19	36,197	$4.25	$153.8K	1,081,253	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-03-27	2025-03-28	138,574	$6.04	$837.0K	1,117,450	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-03-06	2025-03-07	20,000	—	$0	5,896,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-03-06	2025-03-07	20,000	—	$0	1,276,024	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-03-06	2025-03-07	20,000	$6.37	$127.4K	1,256,024	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-03-05	2025-03-07	20,000	—	$0	5,916,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-03-05	2025-03-07	20,000	$6.58	$131.6K	1,256,024	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-03-05	2025-03-07	20,000	—	$0	1,276,024	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2025-02-18	2025-02-20	17,132	$10.64	$182.3K	1,256,024	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-02-06	2025-02-07	20,000	—	$0	5,936,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-02-06	2025-02-07	20,000	—	$0	1,293,156	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-02-06	2025-02-07	20,000	$8.12	$162.4K	1,273,156	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-02-05	2025-02-07	20,000	—	$0	5,956,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-02-05	2025-02-07	20,000	$7.68	$153.6K	1,273,156	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-02-05	2025-02-07	20,000	—	$0	1,293,156	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award deriv	2025-02-03	2025-02-05	1,050,567	—	$0	1,050,567	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award	2025-02-03	2025-02-05	16,809	—	$0	1,278,725	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2025-02-03	2025-02-05	5,569	$7.25	$40.4K	1,273,156	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award	2025-02-03	2025-02-05	525,283	—	$0	1,261,916	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-01-10	2025-01-13	20,000	—	$0	5,976,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-01-10	2025-01-13	20,000	—	$0	756,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-01-10	2025-01-13	20,000	$7.05	$141.0K	736,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2025-01-08	2025-01-13	20,000	—	$0	5,996,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2025-01-08	2025-01-13	20,000	$7.31	$146.2K	736,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2025-01-08	2025-01-13	20,000	—	$0	756,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-12-05	2024-12-06	20,000	—	$0	6,016,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-12-05	2024-12-06	20,000	—	$0	756,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-12-05	2024-12-06	20,000	$7.12	$142.4K	736,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-12-04	2024-12-06	20,000	—	$0	6,036,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-12-04	2024-12-06	20,000	$7.16	$143.2K	736,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-12-04	2024-12-06	20,000	—	$0	756,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2024-11-15	2024-11-19	26,023	$6.18	$160.8K	736,633	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-11-14	2024-11-15	20,000	—	$0	6,056,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-11-14	2024-11-15	20,000	$7.35	$147.0K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-11-14	2024-11-15	20,000	—	$0	782,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-11-13	2024-11-15	20,000	—	$0	6,076,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-11-13	2024-11-15	20,000	$7.74	$154.8K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-11-13	2024-11-15	20,000	—	$0	782,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-10-03	2024-10-04	20,000	—	$0	6,096,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-10-03	2024-10-04	20,000	—	$0	782,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-10-03	2024-10-04	20,000	$6.08	$121.6K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-10-02	2024-10-04	20,000	—	$0	6,116,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-10-02	2024-10-04	20,000	—	$0	782,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-10-02	2024-10-04	20,000	$6.16	$123.2K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-09-05	2024-09-06	20,000	—	$0	6,136,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-09-05	2024-09-06	20,000	$6.14	$122.8K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-09-05	2024-09-06	20,000	—	$0	782,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-09-04	2024-09-06	20,000	—	$0	6,156,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-09-04	2024-09-06	20,000	—	$0	782,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-09-04	2024-09-06	20,000	$6.04	$120.8K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-08-30	2024-08-30	5,000	—	$0	282,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-08-30	2024-08-30	5,000	$2.48	$12.4K	762,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-08-29	2024-08-29	5,000	—	$0	287,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-08-29	2024-08-29	5,000	$2.48	$12.4K	757,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-08-28	2024-08-28	5,000	—	$0	292,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-08-28	2024-08-28	5,000	$2.48	$12.4K	752,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-08-27	2024-08-27	5,000	—	$0	297,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-08-27	2024-08-27	5,000	$2.48	$12.4K	747,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-08-26	2024-08-26	5,000	—	$0	302,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-08-26	2024-08-26	5,000	$2.48	$12.4K	742,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-08-23	2024-08-23	5,000	—	$0	307,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-08-23	2024-08-23	5,000	$2.48	$12.4K	737,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2024-08-15	2024-08-19	26,082	$6.69	$174.5K	732,656	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-08-08	2024-08-09	20,000	—	$0	6,176,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-08-08	2024-08-09	20,000	$6.50	$130.0K	758,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-08-08	2024-08-09	20,000	—	$0	778,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-08-07	2024-08-09	30,000	—	$0	6,196,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-08-07	2024-08-09	30,000	$7.10	$213.0K	758,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-08-07	2024-08-09	30,000	—	$0	788,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-07-11	2024-07-12	50,000	—	$0	6,226,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-07-11	2024-07-12	50,000	—	$0	808,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-07-11	2024-07-12	50,000	$7.47	$373.5K	758,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-07-10	2024-07-12	50,000	—	$0	6,276,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-07-10	2024-07-12	50,000	$7.48	$374.0K	758,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-07-10	2024-07-12	50,000	—	$0	808,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-07-10	2024-07-12	25,000	—	$0	758,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-06-06	2024-06-07	50,000	$9.00	$450.0K	708,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-06-05	2024-07-12	100,000	—	$0	6,326,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-06-05	2024-07-12	100,000	—	$0	908,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-06-05	2024-06-07	25,000	—	$0	6,401,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-06-05	2024-06-07	50,000	$8.42	$421.0K	758,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-06-05	2024-06-07	25,000	—	$0	808,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-06-05	2024-06-07	25,000	—	$0	833,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2024-05-15	2024-05-17	26,082	$10.01	$261.1K	808,738	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-05-02	2024-05-03	21,296	—	$0	6,426,700	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-05-02	2024-05-03	28,704	$8.47	$243.1K	834,820	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-05-02	2024-05-03	21,296	$8.47	$180.4K	834,820	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-05-02	2024-05-03	21,296	—	$0	856,116	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-05-01	2024-05-03	25,000	—	$0	913,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-05-01	2024-05-03	50,000	$7.73	$386.5K	863,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-04-04	2024-04-05	25,000	—	$0	486,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-04-04	2024-04-05	25,000	$9.02	$225.5K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-04-04	2024-04-05	25,000	—	$0	25,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-04-04	2024-04-05	40,000	$9.02	$360.8K	938,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-04-03	2024-04-05	25,000	—	$0	67,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-04-03	2024-04-05	25,000	$8.84	$221.0K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-04-03	2024-04-05	25,000	—	$0	25,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-04-03	2024-04-05	40,000	$8.84	$353.6K	978,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-04-03	2024-04-05	25,000	—	$0	1,018,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-03-28	2024-04-01	25,000	—	$0	92,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-03-28	2024-04-01	25,000	$10.10	$252.5K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-03-28	2024-04-01	25,000	—	$0	1,083,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-03-28	2024-04-01	40,000	$10.10	$404.0K	1,043,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-03-28	2024-04-01	25,000	—	$0	25,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-03-06	2024-03-08	31,250	—	$0	312,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-03-06	2024-03-08	1,000	—	$0	117,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-03-06	2024-03-08	10,000	—	$0	6,461,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-03-06	2024-03-08	20,000	—	$0	388,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-03-06	2024-03-08	4,000	—	$0	511,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-03-06	2024-03-08	8,674	—	$0	399,002	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-03-06	2024-03-08	10,000	—	$0	1,114,919	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-03-06	2024-03-08	31,250	$2.48	$77.5K	1,136,169	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-03-06	2024-03-08	36,319	$11.86	$430.7K	1,108,524	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-03-06	2024-03-08	8,674	$11.40	$98.9K	1,144,843	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-03-06	2024-03-08	10,000	—	$0	1,104,919	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-03-06	2024-03-08	4,000	—	$0	4,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-03-06	2024-03-08	4,000	$11.56	$46.2K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-03-06	2024-03-08	20,000	—	$0	20,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-03-06	2024-03-08	20,000	$11.55	$231.0K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-03-06	2024-03-08	1,000	—	$0	1,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-03-06	2024-03-08	1,000	$11.56	$11.6K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2024-02-15	2024-02-16	11,148	$12.43	$138.6K	1,104,919	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award deriv	2024-02-09	2024-02-13	666,898	—	$0	666,898	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2024-02-09	2024-02-13	3,233	$10.09	$32.6K	1,116,067	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award	2024-02-09	2024-02-13	333,449	—	$0	1,119,300	SEC↗
RXRX RECURSION PHARMACEUTICALS,	A Award	2024-02-09	2024-02-13	11,148	—	$0	785,851	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-02-07	2024-02-09	31,250	—	$0	343,750	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-02-07	2024-02-09	10,000	—	$0	6,471,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-02-07	2024-02-09	10,000	—	$0	801,725	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-02-07	2024-02-09	10,000	—	$0	791,725	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-02-07	2024-02-09	31,250	$2.48	$77.5K	822,975	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-02-07	2024-02-09	48,272	$9.22	$445.1K	774,703	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-01-03	2024-01-05	1,000	—	$0	118,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-01-03	2024-01-05	20,000	—	$0	408,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-01-03	2024-01-05	4,000	—	$0	515,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2024-01-03	2024-01-05	10,000	—	$0	6,481,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2024-01-03	2024-01-05	31,250	—	$0	375,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2024-01-03	2024-01-05	31,250	$2.48	$77.5K	822,578	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-01-03	2024-01-05	30,853	$9.49	$292.8K	791,725	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-01-03	2024-01-05	4,000	$9.51	$38.0K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2024-01-03	2024-01-05	10,000	—	$0	791,328	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-01-03	2024-01-05	10,000	—	$0	801,328	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-01-03	2024-01-05	1,000	$9.49	$9.5K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-01-03	2024-01-05	4,000	—	$0	4,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-01-03	2024-01-05	20,000	—	$0	20,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2024-01-03	2024-01-05	20,000	$9.51	$190.2K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2024-01-03	2024-01-05	1,000	—	$0	1,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-12-06	2023-12-08	31,250	—	$0	406,250	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-12-06	2023-12-08	10,000	—	$0	6,491,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-12-06	2023-12-08	10,000	—	$0	829,907	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-12-06	2023-12-08	59,829	$7.49	$448.1K	791,328	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2023-12-06	2023-12-08	10,000	—	$0	819,907	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2023-12-06	2023-12-08	31,250	$2.48	$77.5K	851,157	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2023-11-15	2023-11-17	16,913	$7.18	$121.4K	819,907	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-11-10	2023-11-17	10,000	—	$0	6,501,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2023-11-10	2023-11-17	10,000	—	$0	836,820	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-11-10	2023-11-17	10,000	—	$0	846,820	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-11-01	2023-11-03	4,000	—	$0	519,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-11-01	2023-11-03	20,000	—	$0	428,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-11-01	2023-11-03	1,000	—	$0	119,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-11-01	2023-11-03	31,250	—	$0	437,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-11-01	2023-11-03	4,000	$5.14	$20.6K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-11-01	2023-11-03	1,000	—	$0	1,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-11-01	2023-11-03	20,000	$5.11	$102.2K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-11-01	2023-11-03	20,000	—	$0	20,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-11-01	2023-11-03	1,000	$5.14	$5.1K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-11-01	2023-11-03	4,000	—	$0	4,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-11-01	2023-11-03	37,177	$5.20	$193.3K	836,820	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2023-11-01	2023-11-03	31,250	$2.48	$77.5K	873,997	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-10-16	2023-10-18	10,000	—	$0	6,501,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-10-16	2023-10-18	10,000	—	$0	852,747	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2023-10-16	2023-10-18	10,000	—	$0	842,747	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-10-04	2023-10-06	31,250	—	$0	468,750	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-10-04	2023-10-06	59,794	$7.21	$431.1K	842,747	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2023-10-04	2023-10-06	31,250	$2.48	$77.5K	902,541	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-09-15	2023-09-19	10,000	—	$0	6,511,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2023-09-15	2023-09-19	10,000	—	$0	871,291	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-09-15	2023-09-19	10,000	—	$0	881,291	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-09-06	2023-09-08	1,000	—	$0	120,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-09-06	2023-09-08	4,000	—	$0	523,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-09-06	2023-09-08	31,250	—	$0	500,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-09-06	2023-09-08	20,000	—	$0	448,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-09-06	2023-09-08	33,765	$8.78	$296.5K	871,291	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2023-09-06	2023-09-08	31,250	$2.48	$77.5K	905,056	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-09-06	2023-09-08	1,000	—	$0	1,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-09-06	2023-09-08	4,000	—	$0	4,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-09-06	2023-09-08	1,000	$8.84	$8.8K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-09-06	2023-09-08	20,000	$8.83	$176.6K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-09-06	2023-09-08	20,000	—	$0	20,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-09-06	2023-09-08	4,000	$8.83	$35.3K	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	F Tax w/h	2023-08-15	2023-08-17	16,913	$9.19	$155.4K	873,806	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-08-09	2023-08-11	10,000	—	$0	6,521,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-08-09	2023-08-11	10,000	—	$0	900,719	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2023-08-09	2023-08-11	10,000	—	$0	890,719	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-08-02	2023-08-04	31,250	—	$0	531,250	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-08-02	2023-08-04	8,674	—	$0	407,676	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2023-08-02	2023-08-04	31,250	$2.48	$77.5K	955,734	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-08-02	2023-08-04	60,955	$13.02	$793.6K	894,779	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-08-02	2023-08-04	4,060	$13.36	$54.2K	890,719	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise	2023-08-02	2023-08-04	8,674	$11.40	$98.9K	924,484	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-07-20	2023-07-21	10,000	—	$0	6,531,496	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-07-20	2023-07-21	10,000	—	$0	925,810	SEC↗
RXRX RECURSION PHARMACEUTICALS,	G Gift	2023-07-20	2023-07-21	10,000	—	$0	915,810	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-07-12	2023-07-14	4,000	—	$0	527,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	M Exercise deriv	2023-07-12	2023-07-14	31,250	—	$0	562,500	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-07-12	2023-07-14	1,000	—	$0	121,875	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion deriv	2023-07-12	2023-07-14	20,000	—	$0	468,000	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-07-12	2023-07-14	13	$14.85	$193	0	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-07-12	2023-07-14	63	$13.75	$866	13	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-07-12	2023-07-14	127	$12.36	$1.6K	76	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-07-12	2023-07-14	561	$11.82	$6.6K	203	SEC↗
RXRX RECURSION PHARMACEUTICALS,	S Sale	2023-07-12	2023-07-14	236	$10.87	$2.6K	764	SEC↗
RXRX RECURSION PHARMACEUTICALS,	C Conversion	2023-07-12	2023-07-14	1,000	—	$0	1,000	SEC↗